InvestorsHub Logo

farrell90

05/29/21 12:53 PM

#360788 RE: StockJumper25 #360778

Kevetrin is a P53 drug. Unless the tumor genetic profile testing also showed a P53 mutation it is unlikely to be effective.

Many cancers have multiple genetic mutations. P53 mutations are not uncommon in non small cell lung cancer.

https://cancerci.biomedcentral.com/articles/10.1186/s12935-019-0910-2

Hopefully IPIX will have the resources to study Kevetrin completely some day.

GLTA Farrell